Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Copenhagen – page 17

771 clinical trials in Copenhagen, Denmark across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Copenhagen at a glance
771
clinical trials
  • Research sites8
Type of trial
Recruitment status
Quick filters

771 trials in Copenhagen

Open in trial search

Glycogen storage disease type I

Recruiting

Study on Long-Term Safety and Pregnancy Outcomes of Pariglasgene Brecaparvovec in Patients with Glycogen Storage Disease Type Ia (GSDIa)

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pariglasgene Brecaparvovec
  • Sponsor:Ultragenyx Pharmaceutical Inc.

Cystic fibrosis

Recruiting

Study of VX-121, Tezacaftor, and Deutivacaftor for Children Aged 1-11 with Cystic Fibrosis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Deutivacaftor
  • Sponsor:Vertex Pharmaceuticals Inc.

Central nervous system lymphoma+4

Recruiting

Study on Golcadomide and Valemetostat Tosylate for Patients with Relapsed or Refractory Non-Hodgkin Lymphomas

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Golcadomide
  • Sponsor:Celgene Corp.

Cardiac arrest

Recruiting

Study on the Effects of Esketamine Hydrochloride and Propofol for Patients After Cardiac Arrest

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Propofol
  • Sponsor:Region Hovedstaden

Myotonic dystrophy

Recruiting

Long-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Mexiletine Hydrochloride
  • Sponsor:Lupin Atlantis Holdings SA

Acute lymphocytic leukaemia+4

Recruiting

Study of Ruxolitinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with IL-7R/JAK-STAT Pathway Mutations

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Ruxolitinib
  • Sponsor:Princess Maxima Center For Pediatric Oncology

Anaplastic large cell lymphoma T- and null-cell types+1

Recruiting

Study of Brigatinib for Children and Young Adults with ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors, or Other Solid Tumors

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Brigatinib
  • Sponsor:Princess Maxima Center For Pediatric Oncology

Retinal artery occlusion

Recruiting

Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Oslo University Hospital HF

Cardiac ventricular thrombosis+1

Recruiting

Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska Institutet

Medulloblastoma

Recruiting

Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:The University Of Birmingham

Hereditary ataxia+1

Recruiting

Study on the Safety of VO659 for Patients with Spinocerebellar Ataxia Types 1, 3, and Huntington's Disease

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Vo659
  • Sponsor:Vico Therapeutics B.V.

Anaesthetic complication neurological

Recruiting

Evaluating the effects of intravenous melatonin for preventing agitation and emergence delirium in children undergoing elective surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Melatonin
  • Sponsor:Region Hovedstaden

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Copenhagen

What the registry says about research in the country

01 Respiratory & Pulmonary Studies

Clinical research focusing on chronic obstructive pulmonary disease (COPD) and nasal conditions, evaluating new therapeutic approaches for respiratory disorders.

  • COPD Treatment Evaluation
  • Chronic Rhinosinusitis Management
  • Nasal Polyps Research

Studies aim to improve treatment outcomes and quality of life for patients with respiratory conditions.

02 Metabolic & Endocrine Research

Investigations into early-onset obesity and related metabolic disorders, with emphasis on innovative treatment approaches.

  • Obesity Management
  • Metabolic Disease Treatments
  • Clinical Weight Management

Focus on developing effective interventions for weight-related health conditions.

03 Mental Health Studies

Research addressing postpartum depression and psychiatric disorders, including innovative hormone therapy approaches and sleep disorders.

  • Maternal Mental Health
  • Insomnia Treatment
  • Depression Prevention

Emphasis on developing targeted treatments for specific mental health conditions.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.